Abiopharma

Director Howard Jeffrey A. 🟡 adjusted position in 73.8K shares of Atlanticus Holdings Corp (ATLC) at $54.67 Transaction Date: Mar 19, 2026 | Filing ID: 009474

McCamey William 🟡 adjusted position in 18.2K shares of Atlanticus Holdings Corp (ATLC) at $54.67 Transaction Date: Mar 19, 2026 | Filing ID: 009473

Marks Gilbert Lynn 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120230

Aziz Kabeer 🟡 adjusted position in 0 shares (4 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120226

Martin Patricia A. 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120223

FitzPatrick Margaret M 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $18.24 Transaction Date: Mar 19, 2026 | Filing ID: 120221

Director deBeers Kimberly A. 🟢 acquired 1.6K shares of ACI WORLDWIDE, INC. (ACIW) Transaction Date: Mar 19, 2026 | Filing ID: 000009

Wong Stephanie 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120216

Zakrzewski Joseph S 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 ($1.5M) Transaction Date: Mar 19, 2026 | Filing ID: 120214

📋 Silver Lake Technology Investors V, L.P. (See remarks) plans to sell 2K shares of Dell Technologies Inc. (at $157.67 each, total $260K) Filed: Mar 23, 2026 | ID: 120212